Skip to main content

Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging.

Publication ,  Journal Article
Petrella, JR; Prince, SE; Krishnan, S; Husn, H; Kelley, L; Doraiswamy, PM
Published in: AJNR Am J Neuroradiol
February 2009

BACKGROUND AND PURPOSE: Cholinesterase-inhibitor therapy is approved for treatment of Alzheimer disease; however, application in patients with mild cognitive impairment (MCI) is still under active investigation. The purpose of this study was to determine the effect of such therapy on the neural substrates underlying memory processing in subjects with MCI by using functional MR imaging (fMRI). MATERIALS AND METHODS: Thirteen subjects with MCI (mean age, 68 +/- 6.9 years) enrolled in a multicenter double-blind placebo-controlled trial testing the clinical efficacy of the cholinesterase-inhibitor, donepezil, were studied with fMRI at baseline and following 12 or 24 weeks of therapy (single-site pilot study). The cognitive paradigm was delayed-response visual memory for novel faces. Within-group 1-sample t tests were performed on the donepezil and placebo groups at baseline and at follow-up. A repeated-measures analysis of variance design was used to look for a Treatment Group x Time interaction showing a significant donepezil- but not placebo-related change in blood oxygen level-dependent response during the course of the study. RESULTS: At baseline, both groups showed multiple areas of activation, including the bilateral dorsolateral prefrontal cortex, fusiform gyrus, and anterior cingulate cortex. On follow-up, the placebo group demonstrated a decreased extent of dorsolateral prefrontal activation, whereas the donepezil group demonstrated an increased extent of activation in the ventrolateral prefrontal cortex. Interaction demonstrated significant donepezil- but not placebo-related change in the left inferior frontal gyrus. CONCLUSIONS: Despite the limitations inherent to a pilot study of a small sample, our results point to specific cortical substrates underlying the actions of donepezil, which can be tested in future studies.

Duke Scholars

Published In

AJNR Am J Neuroradiol

DOI

EISSN

1936-959X

Publication Date

February 2009

Volume

30

Issue

2

Start / End Page

411 / 416

Location

United States

Related Subject Headings

  • Severity of Illness Index
  • Placebos
  • Piperidines
  • Pilot Projects
  • Nuclear Medicine & Medical Imaging
  • Nootropic Agents
  • Middle Aged
  • Memory
  • Male
  • Magnetic Resonance Imaging
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Petrella, J. R., Prince, S. E., Krishnan, S., Husn, H., Kelley, L., & Doraiswamy, P. M. (2009). Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging. AJNR Am J Neuroradiol, 30(2), 411–416. https://doi.org/10.3174/ajnr.A1359
Petrella, J. R., S. E. Prince, S. Krishnan, H. Husn, L. Kelley, and P. M. Doraiswamy. “Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging.AJNR Am J Neuroradiol 30, no. 2 (February 2009): 411–16. https://doi.org/10.3174/ajnr.A1359.
Petrella JR, Prince SE, Krishnan S, Husn H, Kelley L, Doraiswamy PM. Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging. AJNR Am J Neuroradiol. 2009 Feb;30(2):411–6.
Petrella, J. R., et al. “Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging.AJNR Am J Neuroradiol, vol. 30, no. 2, Feb. 2009, pp. 411–16. Pubmed, doi:10.3174/ajnr.A1359.
Petrella JR, Prince SE, Krishnan S, Husn H, Kelley L, Doraiswamy PM. Effects of donepezil on cortical activation in mild cognitive impairment: a pilot double-blind placebo-controlled trial using functional MR imaging. AJNR Am J Neuroradiol. 2009 Feb;30(2):411–416.

Published In

AJNR Am J Neuroradiol

DOI

EISSN

1936-959X

Publication Date

February 2009

Volume

30

Issue

2

Start / End Page

411 / 416

Location

United States

Related Subject Headings

  • Severity of Illness Index
  • Placebos
  • Piperidines
  • Pilot Projects
  • Nuclear Medicine & Medical Imaging
  • Nootropic Agents
  • Middle Aged
  • Memory
  • Male
  • Magnetic Resonance Imaging